Wellstat Therapeutics Corporation is a privately-held biopharmaceutical company located in Rockville, Maryland. Dedicated to the discovery, development and commercialization of innovative therapeutics that expand the frontiers of medicine, Wellstat Therapeutics Corporation is committed to improving the lives of patients with chronic and life-threatening diseases.
Wellstat Therapeutics has two approved products,
Xuriden® and Vistogard®
For product medical information, please send an email to email@example.com or call 1-800-914-0071.
Research & Development
Wellstat Therapeutics is developing an extensive and diverse pipeline of novel small molecule therapeutic agents. The Company owns a broad patent portfolio covering this technology and is constantly expanding its intellectual property estate. Wellstat Therapeutics’ pipeline spans the stages of development from discovery through Phase III clinical trials.
Wellmond, a division of Wellstat Therapeutics, has a diverse pipeline which includes FDA-approved products and development-stage therapies based on our proprietary uridine product platform.
Click on each compound name to learn more
Mitochondrial diseases are caused by genetic defects in the function of mitochondria, subcellular organelles involved in the production of energy from food-derived fuels and oxygen. Mitochondrial diseases therefore often affect tissues with a high energy demand, including the heart, central nervous system and muscles. WT501 is active in models of mitochondrial diseases, regardless of the specific molecular defect in the mitochondrial respiratory chain, and has been provided to a limited number of patients on a compassionate use basis. Clinical trials for this indication are planned.
WT501 is also active in models of Alzheimer’s, Huntington’s, and Parkinson’s diseases, which all involve mitochondrial dysfunction as a key feature in their pathogenesis. This investigational compound may address the metabolic dysfunction that is a commonly shared factor in the pathology of these disorders.
Wellstat Therapeutics Corporation
14200 Shady Grove Road, Suite 600
Rockville, MD 20850, USA
Phone: +1 240-631-2500
Fax: +1 240-683-3793